| Firm | Analyst |
|---|---|
| D. Boral Capital | Jason Kolbert |
| H.C. Wainwright & Co. | Matthew Caufield |
| Maxim Group LLC | Michael Okunewitch |
| Rodman & Renshaw | Elemer Piros, Ph.D. |
| Zacks Small-Cap Research | David Bautz, Ph.D. |
FibroBiologics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding FibroBiologics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of FibroBiologics, Inc. or its management. FibroBiologics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.